![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Nicholas L.M. Cruden David E. Newby
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.4, Iss.6, 2004-01, pp. : 345-353
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Trewet CoraLynn B. Shireman Theresa I. Rigler Sally K. Howard Patricia A.
Drugs & Aging, Vol. 24, Iss. 11, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Angiotensin II receptor antagonists challenge ACE inhibitors
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 252, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 437, 2003-01 ,pp. :